Structure

Physi-Chem Properties

Molecular Weight:  676.35
Volume:  666.254
LogP:  2.366
LogD:  2.136
LogS:  -4.076
# Rotatable Bonds:  3
TPSA:  192.44
# H-Bond Aceptor:  12
# H-Bond Donor:  6
# Rings:  7
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.251
Synthetic Accessibility Score:  6.218
Fsp3:  0.833
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.208
MDCK Permeability:  2.1948382709524594e-05
Pgp-inhibitor:  0.999
Pgp-substrate:  0.994
Human Intestinal Absorption (HIA):  0.482
20% Bioavailability (F20%):  0.907
30% Bioavailability (F30%):  0.966

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.156
Plasma Protein Binding (PPB):  77.3216323852539%
Volume Distribution (VD):  0.813
Pgp-substrate:  13.395689010620117%

ADMET: Metabolism

CYP1A2-inhibitor:  0.003
CYP1A2-substrate:  0.952
CYP2C19-inhibitor:  0.011
CYP2C19-substrate:  0.766
CYP2C9-inhibitor:  0.008
CYP2C9-substrate:  0.021
CYP2D6-inhibitor:  0.001
CYP2D6-substrate:  0.058
CYP3A4-inhibitor:  0.381
CYP3A4-substrate:  0.548

ADMET: Excretion

Clearance (CL):  3.799
Half-life (T1/2):  0.662

ADMET: Toxicity

hERG Blockers:  0.052
Human Hepatotoxicity (H-HT):  0.31
Drug-inuced Liver Injury (DILI):  0.032
AMES Toxicity:  0.049
Rat Oral Acute Toxicity:  0.167
Maximum Recommended Daily Dose:  0.939
Skin Sensitization:  0.027
Carcinogencity:  0.876
Eye Corrosion:  0.003
Eye Irritation:  0.007
Respiratory Toxicity:  0.966

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC277191

Natural Product ID:  NPC277191
Common Name*:   ACPPAFATSKFQFS-YTBYLDSSSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  ACPPAFATSKFQFS-YTBYLDSSSA-N
Standard InCHI:  InChI=1S/C36H52O12/c1-16-24-20(47-35(43)15-30(2,3)48-36(16,35)44)12-32(6)22-10-9-17-18(34(22,8)23(38)13-33(24,32)7)11-19(28(42)31(17,4)5)45-29-27(41)26(40)25(39)21(14-37)46-29/h9,11,16,18,20-22,24-27,29,37,39-41,43-44H,10,12-15H2,1-8H3/t16-,18+,20+,21+,22-,24-,25+,26-,27+,29+,32-,33+,34-,35-,36-/m0/s1
SMILES:  OC[C@H]1O[C@@H](OC2=C[C@@H]3C(=CC[C@@H]4[C@@]3(C)C(=O)C[C@]3([C@@]4(C)C[C@@H]4[C@@H]3[C@H](C)[C@]3([C@](O4)(O)CC(O3)(C)C)O)C)C(C2=O)(C)C)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1923780
PubChem CID:   56833654
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001013] Steroidal glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30742 Machilus yaoshansis Species Lauraceae Eukaryota n.a. root n.a. PMID[22044245]
NPO30742 Machilus yaoshansis Species Lauraceae Eukaryota root Dayao Mountain, Guangxi, China 2007-DEC PMID[22044245]
NPO30742 Machilus yaoshansis Species Lauraceae Eukaryota Roots n.a. n.a. PMID[22779787]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT179 Cell Line A2780 Homo sapiens IC50 > 10000.0 nM PMID[471427]
NPT180 Cell Line HCT-8 Homo sapiens IC50 > 10000.0 nM PMID[471427]
NPT181 Cell Line Bel-7402 Homo sapiens IC50 > 10000.0 nM PMID[471427]
NPT81 Cell Line A549 Homo sapiens IC50 > 10000.0 nM PMID[471427]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 10000.0 nM PMID[471427]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC277191 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC190846
0.9565 High Similarity NPC42675
0.9407 High Similarity NPC93368
0.9402 High Similarity NPC141196
0.9402 High Similarity NPC238005
0.9402 High Similarity NPC1980
0.925 High Similarity NPC69273
0.925 High Similarity NPC293623
0.925 High Similarity NPC168899
0.9244 High Similarity NPC198714
0.9167 High Similarity NPC152091
0.9153 High Similarity NPC216866
0.9098 High Similarity NPC241008
0.9 High Similarity NPC475194
0.8943 High Similarity NPC213634
0.8833 High Similarity NPC131824
0.8803 High Similarity NPC31797
0.8793 High Similarity NPC477944
0.876 High Similarity NPC476542
0.876 High Similarity NPC228701
0.875 High Similarity NPC476543
0.875 High Similarity NPC476544
0.875 High Similarity NPC476545
0.8739 High Similarity NPC161738
0.8689 High Similarity NPC473505
0.8689 High Similarity NPC6615
0.8689 High Similarity NPC7850
0.8678 High Similarity NPC475431
0.8655 High Similarity NPC176005
0.8618 High Similarity NPC104427
0.8595 High Similarity NPC249553
0.8595 High Similarity NPC182900
0.8583 High Similarity NPC473920
0.8583 High Similarity NPC319570
0.8559 High Similarity NPC474557
0.8548 High Similarity NPC292290
0.8548 High Similarity NPC2757
0.8537 High Similarity NPC177820
0.8537 High Similarity NPC30188
0.8525 High Similarity NPC15918
0.8525 High Similarity NPC169816
0.8525 High Similarity NPC94072
0.8525 High Similarity NPC305771
0.8475 Intermediate Similarity NPC260665
0.8455 Intermediate Similarity NPC227397
0.8448 Intermediate Similarity NPC246205
0.8443 Intermediate Similarity NPC278163
0.8443 Intermediate Similarity NPC187950
0.843 Intermediate Similarity NPC279143
0.8403 Intermediate Similarity NPC471398
0.8403 Intermediate Similarity NPC165439
0.839 Intermediate Similarity NPC474265
0.839 Intermediate Similarity NPC130427
0.839 Intermediate Similarity NPC210420
0.8387 Intermediate Similarity NPC469842
0.8387 Intermediate Similarity NPC469841
0.8376 Intermediate Similarity NPC27551
0.8376 Intermediate Similarity NPC114961
0.8374 Intermediate Similarity NPC28532
0.8362 Intermediate Similarity NPC473288
0.8359 Intermediate Similarity NPC475487
0.8348 Intermediate Similarity NPC63023
0.8348 Intermediate Similarity NPC95243
0.8347 Intermediate Similarity NPC475632
0.8347 Intermediate Similarity NPC86020
0.8346 Intermediate Similarity NPC803
0.832 Intermediate Similarity NPC47113
0.832 Intermediate Similarity NPC174367
0.8319 Intermediate Similarity NPC178981
0.8319 Intermediate Similarity NPC73455
0.8319 Intermediate Similarity NPC200944
0.8293 Intermediate Similarity NPC275675
0.8293 Intermediate Similarity NPC133506
0.8293 Intermediate Similarity NPC202051
0.8291 Intermediate Similarity NPC304495
0.8291 Intermediate Similarity NPC470257
0.8281 Intermediate Similarity NPC471855
0.8279 Intermediate Similarity NPC127530
0.8268 Intermediate Similarity NPC309096
0.8268 Intermediate Similarity NPC54614
0.8261 Intermediate Similarity NPC100955
0.8261 Intermediate Similarity NPC121566
0.8254 Intermediate Similarity NPC329784
0.8254 Intermediate Similarity NPC240070
0.825 Intermediate Similarity NPC473882
0.825 Intermediate Similarity NPC477580
0.825 Intermediate Similarity NPC74727
0.824 Intermediate Similarity NPC130229
0.822 Intermediate Similarity NPC163314
0.822 Intermediate Similarity NPC154856
0.822 Intermediate Similarity NPC52241
0.822 Intermediate Similarity NPC475317
0.8211 Intermediate Similarity NPC471406
0.8211 Intermediate Similarity NPC475187
0.819 Intermediate Similarity NPC162033
0.819 Intermediate Similarity NPC210178
0.8189 Intermediate Similarity NPC475636
0.8189 Intermediate Similarity NPC295220
0.8182 Intermediate Similarity NPC279638
0.8175 Intermediate Similarity NPC285091
0.8168 Intermediate Similarity NPC127656
0.8168 Intermediate Similarity NPC141215
0.8168 Intermediate Similarity NPC190065
0.8168 Intermediate Similarity NPC471089
0.8167 Intermediate Similarity NPC251309
0.8167 Intermediate Similarity NPC194100
0.8154 Intermediate Similarity NPC478069
0.8145 Intermediate Similarity NPC475182
0.8145 Intermediate Similarity NPC241310
0.8145 Intermediate Similarity NPC131841
0.8145 Intermediate Similarity NPC194310
0.8145 Intermediate Similarity NPC412
0.8145 Intermediate Similarity NPC258789
0.8145 Intermediate Similarity NPC258815
0.8145 Intermediate Similarity NPC169727
0.8145 Intermediate Similarity NPC47567
0.814 Intermediate Similarity NPC155529
0.814 Intermediate Similarity NPC473805
0.814 Intermediate Similarity NPC473519
0.8136 Intermediate Similarity NPC118225
0.813 Intermediate Similarity NPC190939
0.813 Intermediate Similarity NPC197003
0.8125 Intermediate Similarity NPC276838
0.8125 Intermediate Similarity NPC329986
0.8125 Intermediate Similarity NPC140092
0.8125 Intermediate Similarity NPC232785
0.8125 Intermediate Similarity NPC188234
0.8125 Intermediate Similarity NPC125077
0.8125 Intermediate Similarity NPC471407
0.812 Intermediate Similarity NPC58370
0.812 Intermediate Similarity NPC43285
0.8115 Intermediate Similarity NPC309433
0.811 Intermediate Similarity NPC305496
0.8106 Intermediate Similarity NPC295885
0.8106 Intermediate Similarity NPC596
0.8106 Intermediate Similarity NPC140045
0.8103 Intermediate Similarity NPC223741
0.8092 Intermediate Similarity NPC262813
0.8092 Intermediate Similarity NPC158350
0.8083 Intermediate Similarity NPC233003
0.808 Intermediate Similarity NPC313528
0.808 Intermediate Similarity NPC156789
0.808 Intermediate Similarity NPC471965
0.8077 Intermediate Similarity NPC102015
0.8067 Intermediate Similarity NPC129340
0.8065 Intermediate Similarity NPC170814
0.8065 Intermediate Similarity NPC308459
0.8062 Intermediate Similarity NPC173347
0.8051 Intermediate Similarity NPC272576
0.8047 Intermediate Similarity NPC311534
0.8047 Intermediate Similarity NPC245094
0.8045 Intermediate Similarity NPC290746
0.8045 Intermediate Similarity NPC79250
0.8034 Intermediate Similarity NPC181845
0.8033 Intermediate Similarity NPC235539
0.8033 Intermediate Similarity NPC152199
0.8033 Intermediate Similarity NPC189126
0.8033 Intermediate Similarity NPC134869
0.8031 Intermediate Similarity NPC87662
0.803 Intermediate Similarity NPC251998
0.8017 Intermediate Similarity NPC471627
0.8017 Intermediate Similarity NPC293038
0.8017 Intermediate Similarity NPC62696
0.8017 Intermediate Similarity NPC471173
0.8016 Intermediate Similarity NPC27363
0.8016 Intermediate Similarity NPC14617
0.8016 Intermediate Similarity NPC471961
0.8016 Intermediate Similarity NPC160084
0.8016 Intermediate Similarity NPC262199
0.8016 Intermediate Similarity NPC471964
0.8016 Intermediate Similarity NPC202666
0.8016 Intermediate Similarity NPC256983
0.8 Intermediate Similarity NPC476675
0.8 Intermediate Similarity NPC476672
0.8 Intermediate Similarity NPC477073
0.8 Intermediate Similarity NPC274833
0.7984 Intermediate Similarity NPC258592
0.7984 Intermediate Similarity NPC178548
0.7983 Intermediate Similarity NPC42482
0.7983 Intermediate Similarity NPC265655
0.7983 Intermediate Similarity NPC40440
0.7982 Intermediate Similarity NPC56071
0.7982 Intermediate Similarity NPC70733
0.7966 Intermediate Similarity NPC470432
0.7966 Intermediate Similarity NPC113044
0.7966 Intermediate Similarity NPC161676
0.7966 Intermediate Similarity NPC305423
0.7966 Intermediate Similarity NPC14704
0.7966 Intermediate Similarity NPC283829
0.7966 Intermediate Similarity NPC230507
0.7955 Intermediate Similarity NPC171619
0.7953 Intermediate Similarity NPC476674
0.7953 Intermediate Similarity NPC473474
0.7953 Intermediate Similarity NPC471963
0.7953 Intermediate Similarity NPC247315
0.7953 Intermediate Similarity NPC248202
0.7953 Intermediate Similarity NPC318135
0.7953 Intermediate Similarity NPC471962
0.7951 Intermediate Similarity NPC18547
0.7951 Intermediate Similarity NPC116024

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC277191 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8525 High Similarity NPD6370 Approved
0.848 Intermediate Similarity NPD7736 Approved
0.8435 Intermediate Similarity NPD6412 Phase 2
0.8361 Intermediate Similarity NPD6054 Approved
0.8254 Intermediate Similarity NPD8293 Discontinued
0.8211 Intermediate Similarity NPD6059 Approved
0.8145 Intermediate Similarity NPD6016 Approved
0.8145 Intermediate Similarity NPD6015 Approved
0.8095 Intermediate Similarity NPD7492 Approved
0.808 Intermediate Similarity NPD5988 Approved
0.8031 Intermediate Similarity NPD6616 Approved
0.8016 Intermediate Similarity NPD8328 Phase 3
0.7969 Intermediate Similarity NPD7078 Approved
0.7934 Intermediate Similarity NPD8297 Approved
0.7934 Intermediate Similarity NPD6882 Approved
0.7891 Intermediate Similarity NPD7507 Approved
0.7823 Intermediate Similarity NPD6009 Approved
0.7778 Intermediate Similarity NPD6319 Approved
0.7717 Intermediate Similarity NPD7503 Approved
0.771 Intermediate Similarity NPD7319 Approved
0.7647 Intermediate Similarity NPD8170 Clinical (unspecified phase)
0.7638 Intermediate Similarity NPD8294 Approved
0.7638 Intermediate Similarity NPD8377 Approved
0.7634 Intermediate Similarity NPD6033 Approved
0.7603 Intermediate Similarity NPD6881 Approved
0.7603 Intermediate Similarity NPD6899 Approved
0.7603 Intermediate Similarity NPD7320 Approved
0.7583 Intermediate Similarity NPD6675 Approved
0.7583 Intermediate Similarity NPD6402 Approved
0.7583 Intermediate Similarity NPD7128 Approved
0.7583 Intermediate Similarity NPD5739 Approved
0.7581 Intermediate Similarity NPD4632 Approved
0.7578 Intermediate Similarity NPD8296 Approved
0.7578 Intermediate Similarity NPD8380 Approved
0.7578 Intermediate Similarity NPD8335 Approved
0.7578 Intermediate Similarity NPD8379 Approved
0.7578 Intermediate Similarity NPD8378 Approved
0.7578 Intermediate Similarity NPD8033 Approved
0.7561 Intermediate Similarity NPD8130 Phase 1
0.7561 Intermediate Similarity NPD6649 Approved
0.7561 Intermediate Similarity NPD6650 Approved
0.7541 Intermediate Similarity NPD6372 Approved
0.7541 Intermediate Similarity NPD6373 Approved
0.754 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7521 Intermediate Similarity NPD5697 Approved
0.748 Intermediate Similarity NPD7102 Approved
0.748 Intermediate Similarity NPD6883 Approved
0.748 Intermediate Similarity NPD7290 Approved
0.7459 Intermediate Similarity NPD6686 Approved
0.744 Intermediate Similarity NPD8133 Approved
0.7436 Intermediate Similarity NPD6084 Phase 2
0.7436 Intermediate Similarity NPD6083 Phase 2
0.7419 Intermediate Similarity NPD6869 Approved
0.7419 Intermediate Similarity NPD6617 Approved
0.7419 Intermediate Similarity NPD6847 Approved
0.7414 Intermediate Similarity NPD5695 Phase 3
0.7398 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7398 Intermediate Similarity NPD6013 Approved
0.7398 Intermediate Similarity NPD6012 Approved
0.7398 Intermediate Similarity NPD6014 Approved
0.7388 Intermediate Similarity NPD5956 Approved
0.7377 Intermediate Similarity NPD5701 Approved
0.7344 Intermediate Similarity NPD7328 Approved
0.7344 Intermediate Similarity NPD7327 Approved
0.7339 Intermediate Similarity NPD4634 Approved
0.7328 Intermediate Similarity NPD7604 Phase 2
0.7317 Intermediate Similarity NPD6011 Approved
0.7311 Intermediate Similarity NPD4696 Approved
0.7311 Intermediate Similarity NPD5286 Approved
0.7311 Intermediate Similarity NPD5285 Approved
0.7308 Intermediate Similarity NPD5983 Phase 2
0.7288 Intermediate Similarity NPD4755 Approved
0.7287 Intermediate Similarity NPD7516 Approved
0.7218 Intermediate Similarity NPD6336 Discontinued
0.7197 Intermediate Similarity NPD6067 Discontinued
0.719 Intermediate Similarity NPD5225 Approved
0.719 Intermediate Similarity NPD4633 Approved
0.719 Intermediate Similarity NPD5224 Approved
0.719 Intermediate Similarity NPD5226 Approved
0.719 Intermediate Similarity NPD5211 Phase 2
0.7167 Intermediate Similarity NPD4700 Approved
0.7143 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7131 Intermediate Similarity NPD5175 Approved
0.7131 Intermediate Similarity NPD5174 Approved
0.713 Intermediate Similarity NPD4753 Phase 2
0.7107 Intermediate Similarity NPD5223 Approved
0.7087 Intermediate Similarity NPD6053 Discontinued
0.7083 Intermediate Similarity NPD5696 Approved
0.7073 Intermediate Similarity NPD5141 Approved
0.7054 Intermediate Similarity NPD6274 Approved
0.704 Intermediate Similarity NPD4729 Approved
0.704 Intermediate Similarity NPD4730 Approved
0.7023 Intermediate Similarity NPD7100 Approved
0.7023 Intermediate Similarity NPD7101 Approved
0.7016 Intermediate Similarity NPD4767 Approved
0.7016 Intermediate Similarity NPD4768 Approved
0.7016 Intermediate Similarity NPD6008 Approved
0.6975 Remote Similarity NPD4629 Approved
0.6975 Remote Similarity NPD5210 Approved
0.6947 Remote Similarity NPD6335 Approved
0.6929 Remote Similarity NPD5247 Approved
0.6929 Remote Similarity NPD5250 Approved
0.6929 Remote Similarity NPD5249 Phase 3
0.6929 Remote Similarity NPD5251 Approved
0.6929 Remote Similarity NPD5248 Approved
0.6917 Remote Similarity NPD8515 Approved
0.6917 Remote Similarity NPD8516 Approved
0.6917 Remote Similarity NPD8517 Approved
0.6917 Remote Similarity NPD8513 Phase 3
0.6905 Remote Similarity NPD5128 Approved
0.6875 Remote Similarity NPD8413 Clinical (unspecified phase)
0.687 Remote Similarity NPD5690 Phase 2
0.687 Remote Similarity NPD6317 Approved
0.6864 Remote Similarity NPD6050 Approved
0.6861 Remote Similarity NPD8336 Approved
0.6861 Remote Similarity NPD8337 Approved
0.6855 Remote Similarity NPD4754 Approved
0.6838 Remote Similarity NPD6673 Approved
0.6838 Remote Similarity NPD6904 Approved
0.6838 Remote Similarity NPD6080 Approved
0.6818 Remote Similarity NPD6314 Approved
0.6818 Remote Similarity NPD6313 Approved
0.6807 Remote Similarity NPD8171 Discontinued
0.6791 Remote Similarity NPD6909 Approved
0.6791 Remote Similarity NPD6908 Approved
0.6791 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6783 Remote Similarity NPD5329 Approved
0.678 Remote Similarity NPD5692 Phase 3
0.6777 Remote Similarity NPD5221 Approved
0.6777 Remote Similarity NPD5222 Approved
0.6777 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6752 Remote Similarity NPD6672 Approved
0.6752 Remote Similarity NPD5737 Approved
0.675 Remote Similarity NPD5282 Discontinued
0.6744 Remote Similarity NPD5217 Approved
0.6744 Remote Similarity NPD5215 Approved
0.6744 Remote Similarity NPD5216 Approved
0.6741 Remote Similarity NPD8080 Discontinued
0.6724 Remote Similarity NPD4694 Approved
0.6724 Remote Similarity NPD5279 Phase 3
0.6724 Remote Similarity NPD5280 Approved
0.6723 Remote Similarity NPD6079 Approved
0.6723 Remote Similarity NPD5694 Approved
0.6721 Remote Similarity NPD5173 Approved
0.6696 Remote Similarity NPD3666 Approved
0.6696 Remote Similarity NPD3133 Approved
0.6696 Remote Similarity NPD3665 Phase 1
0.6696 Remote Similarity NPD4197 Approved
0.6695 Remote Similarity NPD5328 Approved
0.6693 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8449 Approved
0.6667 Remote Similarity NPD5169 Approved
0.6667 Remote Similarity NPD5135 Approved
0.6667 Remote Similarity NPD4202 Approved
0.6642 Remote Similarity NPD4522 Approved
0.6639 Remote Similarity NPD4697 Phase 3
0.662 Remote Similarity NPD8450 Suspended
0.6617 Remote Similarity NPD7115 Discovery
0.6615 Remote Similarity NPD5127 Approved
0.661 Remote Similarity NPD7513 Clinical (unspecified phase)
0.661 Remote Similarity NPD6903 Approved
0.6596 Remote Similarity NPD7260 Phase 2
0.6583 Remote Similarity NPD5284 Approved
0.6583 Remote Similarity NPD5281 Approved
0.6583 Remote Similarity NPD5693 Phase 1
0.6581 Remote Similarity NPD6684 Approved
0.6581 Remote Similarity NPD7146 Approved
0.6581 Remote Similarity NPD6409 Approved
0.6581 Remote Similarity NPD7521 Approved
0.6581 Remote Similarity NPD5330 Approved
0.6581 Remote Similarity NPD6098 Approved
0.6581 Remote Similarity NPD7334 Approved
0.6557 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6549 Remote Similarity NPD6845 Suspended
0.6544 Remote Similarity NPD8274 Clinical (unspecified phase)
0.6541 Remote Similarity NPD6868 Approved
0.6529 Remote Similarity NPD6399 Phase 3
0.6524 Remote Similarity NPD7799 Discontinued
0.6522 Remote Similarity NPD4221 Approved
0.6522 Remote Similarity NPD4223 Phase 3
0.65 Remote Similarity NPD5207 Approved
0.6475 Remote Similarity NPD7748 Approved
0.6466 Remote Similarity NPD5167 Approved
0.6466 Remote Similarity NPD4788 Approved
0.6452 Remote Similarity NPD7902 Approved
0.6423 Remote Similarity NPD5654 Approved
0.641 Remote Similarity NPD4786 Approved
0.64 Remote Similarity NPD7638 Approved
0.6385 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6349 Remote Similarity NPD7639 Approved
0.6349 Remote Similarity NPD7640 Approved
0.6327 Remote Similarity NPD6334 Approved
0.6327 Remote Similarity NPD6333 Approved
0.632 Remote Similarity NPD5959 Approved
0.6319 Remote Similarity NPD8338 Approved
0.6311 Remote Similarity NPD7515 Phase 2
0.6303 Remote Similarity NPD3618 Phase 1
0.6303 Remote Similarity NPD4689 Approved
0.6303 Remote Similarity NPD4693 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data